Eradication of Malignant Carcinoma in the Breast Tissue

Phase 2

Completed

• Conditions: Breast Cancer
• Interventions: Dietary Supplement: Acetogenins; Dietary Supplement: Placebo

• Registration Number: NCT02286778
• Lead Sponsor: Optimal Health Research

Brief Summary

The purpose of this study is to confirm the findings of an early study and expand our knowledge of treating Malignant Carcinoma in the Breast Tissue Using an ATP (Adenosine-5'-Triphosphate) Inhibitor.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-11-03
• Study First Submitted QC: 2014-11-07
• Study First Posted: 2014-11-10
• Study Start: 2016-02
• Primary Completion: 2017-01
• Status Verified: 2017-08
• Study Completion: 2017-08-01
• Last Update Submitted: 2017-08-02
• Last Update Posted: 2017-08-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• Clinical diagnosis of breast cancer
• Referred to the study by their treating physician

Exclusion Criteria

• Any type of treatment for breast cancer before starting the study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Acetogenins	Acetogenins	Dietary Supplement: Acetogenins BID for 12 months
Placebo	Placebo	Dietary Supplement: No Acetogenins BID for 12 months

Primary Outcome Measures

Name	Time	Method
Number of participants tumor free	12 months	assessed by MRI